Skip to main content
OpenTrials
Completed

NCT Number: NCT06281626

Use of the Free Male Condom Scheme in Young Adults Aged 18 to 25

For several years, the incidence of sexually transmitted infections (STIs) has been rising sharply, while that of HIV has stagnated. This is due to the decline in condom use since the late 1990s, despite the fact that condom are considered the only effective way to prevent STIs.

In France, 40% of STIs concern young people aged 15 to 25. The national public health strategy aims to stem the circulation of HIV and eliminate STIs as a major public health problem by 2030. To achieve this, several measures have been implemented: reimbursement of male condoms on prescription (2018), 100% free contraception and prevention in sexual health consultation (2021), and more recently, free, non-prescription access to male condoms in pharmacies (end 2022).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–25 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ufr Medecine Urca, Reims, France

Loading trial locations.

About this study

The main objective is to describe the use of free male condoms by young adults aged 18 to 25.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 18 to 25 years
  • Male or female
  • Regardless of their sexual orientation
  • Agreeing to participate in the study

Exclusion criteria

  • Minors
  • Refusing to participate in the study.

Treatment and study plan

Data Collection

Other

Data collection

Primary outcomes

  1. use of free male condoms

    Time frame: Day 0

    use of free male condoms recorded as yes or not

Sponsors and collaborators

Lead sponsor

Université de Reims Champagne-Ardenne

Other

Registry information

Acronym: Préservatif

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Feb 28, 2024
Registry last updated
Jun 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.